Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group Plc LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +5.00p +1.37% 370.00p 360.00p 380.00p 370.00p 365.00p 365.00p 28,286 09:54:09
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 67.2 13.9 14.2 26.1 248.35

Eco Animal Health Share Discussion Threads

Showing 676 to 698 of 1025 messages
Chat Pages: Latest  29  28  27  26  25  24  23  22  21  20  19  18  Older
DateSubjectAuthorDiscuss
15/11/2016
22:46
Seems like the odd 20p daily swing is the norm for EAH these days. Wasn't long ago when such a move was in response to major news flow. I guess my brain still hasn't adapted to the fact this is now 4-500p instead of 1-200p. Hopefully next financial update will push us to 600!
audigger
19/10/2016
13:30
We'll put, thank you very much, Au. More to look forward to, clearly. Tejo, on the iii board, says "The regulatory approval for Aivlosinby the Thai authorities,is, in my view, of great sigtnificance because it should open up the whole Asian market. This is because Thailand is a top poultry producer and their approval will very likely lead to approval in most, if not all, Asian countries." Remember my post 666 back in early August. They're undertaking some property development as well. Very enterprising!
aimingupward2
19/10/2016
13:06
Some countries (and I'm not entirely sure if Thailand is one of them) will use the EU approval as a basis for approving the product in their country. They rely on the fact that the data requirements and evaluation process in Europe is extremely thorough such that, if the EU approve it, they will be very likely to approve it. Thus, rather than a full in-depth evaluation over a number of years (as per the EU), the approval is more of an administrative process. Its a form of mutual recognition and often exists between OECD and non-OECD countries. I think there are also mutual recognition agreements in place between other Asian countries (ASEAN - Association of South East Asian Nations) so the approval in Thailand may help expedite other approvals in the region
audigger
19/10/2016
10:14
Not quite sure what you are saying, Au. Do you mean that once a European approval is given, other jurisdictions/authorities are less likely to scrutinise an application very thoroughly and more like to accept a new registration? Or rather that, once the work of drawing up the paperwork for the first submission is done, it neels very little extra effort to submit it to other countries/markets? Anyway, the fact that " ECO has begun the process of submitting the Aivlosin® regulatory files for the treatment of layers in numerous other key egg producing markets" means we can expect a continuing flow of encouraging news in due course.
aimingupward2
19/10/2016
10:02
Today's news is a good example of how you can leverage the EU registration in other countries. Its good to hear that more egg laying registrations are to come
audigger
17/10/2016
15:59
Another interesting jump today. As Hydrus notes, the falling pound will only enhance an already rapidly improving bottom line
audigger
12/10/2016
11:58
Exchange rate got to be a big plus here considering the invoice pretty much all their revenue in dollars
hydrus
01/10/2016
16:41
I have heard of them but bit too blue sky for me, I mainly focus on profitable companies
hydrus
01/10/2016
11:30
I reckon Nanoco (NANO) ought to be on that list. Do you know them Hydro? They're a world leading nanotechnology company. I now see that the Telegraph today also talks of 'a huge £120 million govt cash injection' going into research in artificial intelligence and in nanotechnology.
aimingupward2
01/10/2016
11:19
Clinigen (healthcare,), Patisserie Holdings (owns Patisserie Valerie), and 3 others I didn't know of - Blue Prism ( robotics software, but it's technology 'has limited patent protection'), Eckoh, a 'secure payment'company growing at 20% p.a.'and Vitrex ( supplier of high performance plastics to specialised markets in medical, aerospace, automotive, oil and gas).
aimingupward2
01/10/2016
10:54
Thanks - out of interest what were the others?
hydrus
01/10/2016
10:47
The D Telegraph today looks at 6 British companies that 'could emulate the huge share price gains made by the tonic water maker Fever Tree'. EAH is picked out as one of them!! A bit ott, I would have thought, but a nice show of confidence anyway.
aimingupward2
20/9/2016
12:29
Thanks for that, Au.
aimingupward2
20/9/2016
11:53
Yes they do. They have their own manufacturing facility in China. I remember a number of rns releases a few years back when they were gmp acredited by FDA, Eu,Japan and others.
audigger
20/9/2016
10:02
Do they produce all their Aivlosin themselves, Au, or do they partially or wholly use contract manufacturers?
aimingupward2
20/9/2016
08:19
I guess another consideration is infrastructure. Assuming they have sufficient production capacity, then the large increase in sales appears to be being delivered by the existing infrastructure and therefore without too much additional cost. If regulators move towards selectively authorising molecules with a very low residue profile then Aivlosin may well be quite future prof assuming no issues with resistance. This has to be an attractive proposition for the bigger players in the sector.
audigger
19/9/2016
18:52
Peter Laurence commented at recent AGM that the first 5 months of year were significantly higher than previous year; also benefiting from Brexit / £Sterling fall with its +90% transactions in forex.
ettienne1951
19/9/2016
17:59
If exceptional costs start to unwind then I guess that could help anyway as you highlight
hydrus
19/9/2016
17:58
It's a high quality company which appears to have commenced a period of extended rapid growth. If profits are rising 40% plus then the PE isn't at all stretching.
hydrus
19/9/2016
17:03
JIGSAW47, on the iii site, says "Brokers have today reiterated a buy recommendation with a target price up from 450p to 550p but "continue to see significantly higher value as the business grows and given its strategic value." He also says "PE is the wrong measure to judge as it includes amortisation of the costs of regulatory approvals that are in reality a growing and substantial asset and increasingly so as sales accelerate." I suppose that's a sensible view. What do others think?
aimingupward2
17/9/2016
17:19
Yes, fantastic update. Just wish I'd bought more of these when I did at 93P. Oh well, at least I haven't sold any yet. May sell a few at some point relatively soon. I'd love to see a robust valuation of this company. We all know its great, but no idea how much it's really worth to a major.
topvest
17/9/2016
06:32
Great company here, well done Peter Lawrence and team! They have something very special! However how much longer can this company stay independent??? Particularly given the exchange rate makes it much cheaper for s foreign buyer......
smelleroo
16/9/2016
11:49
CHUCKLE GOOD LUCK ENJOY YOUR DAY AND WEEKEND
waldron
Chat Pages: Latest  29  28  27  26  25  24  23  22  21  20  19  18  Older
Your Recent History
LSE
EAH
Eco Animal..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190527 11:04:46